Clinical Trial Update: Efficacy and Safety of Asenapine in the Prevention of Recurrence of Mood Episodes in Participants With Bipolar 1 Disorder (P06384) [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the efficacy and safety of asenapine in preventing recurrence of mood episodes in Bipolar I Disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bipolar Disorder

Drugs mentioned

• Saphris (asenapine)

Snippet

Sponsor: Forest Laboratories | Conditions: Bipolar 1 Disorder | Phase 3 | Status: COMPLETED